https://retacompare.com/news/advancements-in-glp-1-obesity-drugs-highlight-retatrutide-s-potential 2026-10-25T03:12:05.000Z RetatrutideCompare en 2026-10-25T03:12:05.000Z Advancements in GLP-1 Obesity Drugs Highlight Retatrutide's Potential Market News, Retatrutide https://retacompare.com/news/chemical-analysis-of-unofficial-retatrutide-raises-concerns 2026-10-24T15:55:00.000Z RetatrutideCompare en 2026-10-24T15:55:00.000Z Chemical Analysis of Unofficial Retatrutide Raises Concerns Market News, Retatrutide https://retacompare.com/news/retatrutide-shows-promise-in-reducing-sleep-apnea-in-trials 2026-10-24T15:00:07.000Z RetatrutideCompare en 2026-10-24T15:00:07.000Z Retatrutide Shows Promise in Reducing Sleep Apnea in Trials Clinical Trials, Retatrutide https://retacompare.com/news/eloratzp-achieves-superior-weight-loss-and-a1c-reduction-over-tirzepatide 2026-10-24T14:26:29.000Z RetatrutideCompare en 2026-10-24T14:26:29.000Z EloraTZP Achieves Superior Weight Loss and A1C Reduction Over Tirzepatide Clinical Trials, Retatrutide https://retacompare.com/news/petrelintide-shows-potential-for-fewer-gi-side-effects-than-glp-1-agonists 2026-10-24T11:13:49.000Z RetatrutideCompare en 2026-10-24T11:13:49.000Z Petrelintide Shows Potential for Fewer GI Side Effects than GLP-1 Agonists Weight Loss, Retatrutide https://retacompare.com/news/insights-on-glp-1-agonists-for-optimal-obesity-treatment-outcomes 2026-10-23T18:00:00.000Z RetatrutideCompare en 2026-10-23T18:00:00.000Z Insights on GLP-1 Agonists for Optimal Obesity Treatment Outcomes Weight Loss, Retatrutide https://retacompare.com/news/retatrutide-s-role-in-weight-loss-explored-in-recent-report 2026-10-23T16:59:10.000Z RetatrutideCompare en 2026-10-23T16:59:10.000Z Retatrutide's Role in Weight Loss Explored in Recent Report Weight Loss, Retatrutide